Prawo i regulacje · 18/08/2015

U.S. Federal Trade Commission Approves Pfizer's Acquisition of BioNTech, Following Conditions and Commitments

The U.S. Federal Trade Commission has approved Pfizer's acquisition of BioNTech, subject to certain conditions and commitments, following a thorough review and evaluation process